Quick Answer
NEUROONE MEDICAL TECHNOLOGIES Corp reported Stockholders Equity of $7.07 million for the year ending 2025.
- NEUROONE MEDICAL TECHNOLOGIES Corp showed an increase of +760.4% in Stockholders Equity from 2024 to 2025.
- This data is from NEUROONE MEDICAL TECHNOLOGIES Corp's annual report (Form 10-K), filed with the SEC on December 17, 2025.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2015: -$81.5 thousand | Q1 2016: -$84.7 thousand | Q2 2016: -$99.5 thousand | Q3 2016: -$105.2 thousand | Q1 2017: -$104.9 thousand | Q2 2017: -$128.5 thousand | Q3 2017: -$3.53 million | Q1 2018: -$6.39 million | Q2 2018: -$7.29 million | Q4 2018: -$1.24 million | Q1 2019: $444.6 thousand | Q2 2019: -$273.4 thousand | Q4 2019: -$4.61 million | Q1 2020: -$5.19 million | Q2 2020: -$3.93 million | Q4 2020: $1.41 million | Q1 2021: $10.86 million | Q2 2021: $8.85 million | Q4 2021: $15.95 million | Q1 2022: $13.12 million | Q2 2022: $10.62 million | Q4 2022: $8.17 million | Q1 2023: $5.53 million | Q2 2023: $3.92 million | Q4 2023: $4.42 million | Q1 2024: $3.85 million | Q2 2024: $3.01 million | Q3 2024: $822.0 thousand | Q4 2024: $2.94 million | Q1 2025: $1.13 million | Q2 2025: $8.18 million | Q3 2025: $7.07 million | Q4 2025: $6.40 million.
- Over the full 16 years of available data (2010 to 2025), NEUROONE MEDICAL TECHNOLOGIES Corp's Stockholders Equity has grown by 163,702.2%.
- Historical annual values: Fiscal year 2025: $7.07 million | Fiscal year 2024: $822.0 thousand | Fiscal year 2023: $6.25 million | Fiscal year 2022: $9.60 million | Fiscal year 2021: $6.55 million | Fiscal year 2020: $2.07 million | Fiscal year 2019: -$1.24 million | Fiscal year 2018: -$4.40 million | Fiscal year 2017: -$5.04 million | Fiscal year 2016: -$266.2 thousand | Fiscal year 2015: -$81.5 thousand | Fiscal year 2014: -$35.4 thousand | Fiscal year 2013: -$30.3 thousand | Fiscal year 2012: -$17.2 thousand | Fiscal year 2011: -$3.3 thousand | Fiscal year 2010: -$4.3 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: